Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safeguarding the Brain of Our Smallest Children - an Investigator-initiated, Pragmatic, Open Label, Multinational Randomized Phase IIIclinical Trial Evaluating Treatment Based on Near-infrared Spectroscopy Monitoring Versus Treatment as Usual in Premature Infants

NCT03770741 is registered in ClinicalTrials.gov with Gorm Greisen as lead sponsor.

NCT NCT03770741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03770741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safeguarding the Brain of Our Smallest Children - an Investigator-initiated, Pragmatic, Open Label, Multinational Randomized Phase IIIclinical Trial Evaluating Treatment Based on Near-infrared Spectroscopy Monitoring Versus Treatment as Usual in Premature Infants
Lead sponsor
Gorm Greisen
Phase
Not applicable
Overall status
Completed
Start date
June 20, 2019
Completion date
December 16, 2021
Enrollment
1,601 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain injuries, death, brain, death; neonatal, infant, extremely premature